|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/574 | |
| C07K 16/00 | |||
| G01N 33/68 |
| (11) | Patento numeris | 3250929 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16702782.0 |
| Europos patento paraiškos padavimo data | 2016-01-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-12-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-03-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2016/050200 |
| Data | 2016-01-29 |
| (87) | Numeris | WO 2016/120633 |
| Data | 2016-08-04 |
| (30) | Numeris | Data | Šalis |
| 201501597 | 2015-01-30 | GB |
| (72) |
RUDDOCK, Mark W., IE
REID, Cherith N., IE
WILLIAMSON, Kate E., IE
LAMONT, John, IE
FITZGERALD, Peter, IE
|
| (73) |
Randox Laboratories Ltd.,
Ardmore 55 Diamond Road Crumlin Co. Antrim BT29 4QY, Northern Ireland,
GB
|
| (54) | DIAGNOSIS OF RISK OF UROTHELIAL CANCER |
| DIAGNOSIS OF RISK OF UROTHELIAL CANCER |